Executive Summary
Diabetes and hypertension are among this century’s foremost threats to health and development. They are top contributors to premature death and disability in even the least developed countries. India, with 275 million people affected, is a critical battleground to reverse the global rise and devastation from these conditions. Socio-economically deprived populations are particularly vulnerable to fatal and debilitating health complications from diabetes and hypertension because effective prevention and treatment strategies fail to reach them.
Developed over a decade of field testing across India, Destination Zero is a proven package of digital technology tools and healthcare worker training programs designed to strengthen community outreach and patient engagement. We will reach more than 100 districts covering more than 200 million Indians, enhancing the ability of health systems, healthcare workers, patients, and communities to affordably and equitably prevent and manage these silent killers and disablers.
Charity, fund, non-governmental organization, religious institution, school, or other entity
Organizations may provide budget and employee data based on this proposal or the organization as a whole. For more information on this proposal or organization, please email us.
Accomplishments
Years of life lost due to diabetes nearly doubled between 1990 and 2016, while high blood pressure is the 3rd leading risk factor for death in India (1). Many adults remain undiagnosed (4, 5). In response to the rapid rise of these silent killers, there is mounting political will in India to prevent, screen, and treat these conditions in the community. To ensure feasibility, efficiency, and sustainability, we will dovetail Destination Zero onto the Government of India’s National Health Mission, which recently recommended universal screening of diabetes and hypertension and embed it strategically within existing public health and primary healthcare settings. This builds on previous collaborations with the state governments of Himachal Pradesh, Haryana, Karnataka, Punjab, and Andhra Pradesh to implement, monitor, and evaluate this solution for diabetes and hypertension in community and primary care settings. These partnerships with state health leadership demonstrate local investment in addressing these conditions.
